Opportunity Information: Apply for CDC RFA PS10 1026
Apply for CDC RFA PS10 1026
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Supporting the National Blood Transfusion Service (NBTS) in the Implementation and strengthening of Blood Safety Activities in the Republic of Uganda under the President s Emergency Plan for AIDS Relief (PEPFAR)." and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Jan 15, 2010 and posted on Jan 15, 2010.
- Applicants must submit their applications by Mar 16, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $15,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $5,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- This program is authorized under Public Law 108 25 (the United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act of 2003) 22 U.S.C. 7601, et seq., and Public Law 110 293 (the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, CDC RFA PS10-1026, is a U.S. Centers for Disease Control and Prevention (CDC) cooperative agreement issued under the President's Emergency Plan for AIDS Relief (PEPFAR) to support Uganda's National Blood Transfusion Service (NBTS). Its central public health purpose is to reduce HIV transmission linked to blood transfusions by strengthening blood safety systems and, at the same time, lowering HIV prevalence among blood donors. In practical terms, the award is aimed at helping Uganda maintain and improve a reliable national program that can recruit low-risk donors, collect blood safely, test it accurately, and ensure only safe blood is released for transfusion, while also promoting donor selection and retention strategies that reduce the likelihood of collecting blood from higher-risk populations.
The award mechanism is a cooperative agreement, which typically means CDC expects to be substantially involved in the project beyond routine grant oversight. Rather than simply providing funds and receiving reports, CDC generally works alongside the recipient through technical guidance, collaborative planning, performance monitoring, and alignment with PEPFAR strategies and reporting requirements. The funding activity category is health, and the CFDA number listed is 93.067 (Global AIDS), placing it squarely within the U.S. government global HIV/AIDS portfolio.
Financially, the opportunity anticipated a single award (ExpectedAwards: 1), indicating the intent to fund one main implementing partner to support NBTS at a national level. The estimated total funding across the project was $15,000,000, with an award floor of $3,000,000 and an award ceiling of $5,000,000, suggesting a multi-year structure where annual or budget-period funding might fall within that range. There was no cost sharing or matching requirement, meaning applicants were not required to contribute their own funds as a condition of the award.
The legal authority for the program comes from major U.S. global health statutes: Public Law 108-25 (the United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act of 2003) and Public Law 110-293 (the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008). Those laws provide the basis for PEPFAR programming and support activities that prevent new HIV infections, including transmission through medical procedures such as transfusion.
From an implementation perspective, "strengthening blood safety activities" usually covers the end-to-end chain that keeps the blood supply safe: donor recruitment and retention focused on voluntary, non-remunerated donors; donor education and pre-donation screening to reduce risk; quality-assured blood collection and handling; strong laboratory systems for transfusion-transmissible infection testing (especially HIV, but often also hepatitis B, hepatitis C, and syphilis depending on national policy); and robust quality management systems so that procedures, training, documentation, and corrective actions are consistent across sites. It can also include improving logistics and cold chain systems, inventory management to reduce wastage and shortages, hemovigilance or adverse event monitoring, and data systems that track donors and blood units while protecting confidentiality. The explicit emphasis in the announcement on decreasing HIV prevalence among blood donors points to prevention-oriented donor selection and repeat donor strategies, because repeat voluntary donors who are regularly screened and educated tend to have lower HIV prevalence than first-time or replacement donors.
Key administrative details reflect a standard federal competitive timeline from that period. The opportunity was posted on January 15, 2010, created the same day, with an original and current closing date of March 16, 2010, and an archive date of April 15, 2010. Eligibility is described as "Others (see text field entitled Additional Information on Eligibility for clarification)," which signals that the eligible applicant pool was defined in the full notice rather than being limited to a common single category like state governments or universities. In many CDC international cooperative agreements, this category can include non-profits, NGOs, academic institutions, and other organizations with the demonstrated capacity to implement national-scale public health programs in collaboration with host-country entities, but the specific eligibility conditions would be in the full announcement.
For applicants or stakeholders who had trouble accessing the full announcement, CDC provided a point of contact through PGO TIMS grants at 770-488-2700 and a general email address (as listed in the opportunity). Overall, the opportunity is best understood as a PEPFAR-funded, CDC-supported effort to reinforce Uganda's national blood safety system so that transfusions do not contribute to HIV transmission and so that donor recruitment and screening approaches progressively reduce HIV prevalence within the donor pool.
Frequently Asked Questions (FAQs)
What is the funding opportunity number and who is offering it?
The opportunity is CDC RFA PS10-1026, offered by the U.S. Centers for Disease Control and Prevention (CDC).
What is the main public health purpose of this award?
The central purpose is to reduce HIV transmission linked to blood transfusions in Uganda by strengthening blood safety systems and, at the same time, lowering HIV prevalence among blood donors.
How does the program plan to reduce HIV transmission through transfusion?
By supporting Uganda's National Blood Transfusion Service (NBTS) to maintain and improve a reliable national system that recruits low-risk donors, collects blood safely, tests it accurately, and ensures only safe blood is released for transfusion.
Which country and national program are the focus of this award?
The focus is Uganda, specifically supporting Uganda's National Blood Transfusion Service (NBTS).
What type of funding mechanism is being used?
The award mechanism is a cooperative agreement.
What does a "cooperative agreement" mean in this context?
A cooperative agreement typically means CDC expects to be substantially involved beyond routine grant oversight. CDC may work alongside the recipient through technical guidance, collaborative planning, performance monitoring, and alignment with PEPFAR strategies and reporting requirements.
Is this funding connected to PEPFAR?
Yes. The cooperative agreement is issued under the President's Emergency Plan for AIDS Relief (PEPFAR).
What is the CFDA number for this opportunity and what does it indicate?
The CFDA number listed is 93.067 (Global AIDS), indicating it falls within the U.S. government global HIV/AIDS portfolio.
How many awards were expected to be made?
The opportunity anticipated a single award (ExpectedAwards: 1), indicating an intent to fund one main implementing partner to support NBTS at a national level.
What was the estimated total funding for the project?
The estimated total funding across the project was $15,000,000.
What were the award floor and award ceiling?
The award floor was $3,000,000 and the award ceiling was $5,000,000.
Does the funding range suggest a multi-year project?
Yes. The combination of an estimated total funding amount and an annual or budget-period floor/ceiling suggests a multi-year structure where each budget period could fall within the stated range.
Was cost sharing or matching required?
No. There was no cost sharing or matching requirement, meaning applicants were not required to contribute their own funds as a condition of the award.
What kinds of activities are generally included under "strengthening blood safety activities"?
Based on the description provided, strengthening blood safety can cover the full chain of activities that keeps the blood supply safe, such as donor recruitment and retention focused on low-risk donors; donor education and pre-donation screening; quality-assured blood collection and handling; strong laboratory systems for transfusion-transmissible infection testing; and robust quality management systems across sites.
Does the opportunity mention improving systems beyond collection and testing?
Yes. It can also include improving logistics and cold chain systems, inventory management to reduce wastage and shortages, hemovigilance or adverse event monitoring, and data systems that track donors and blood units while protecting confidentiality.
Is the award focused only on HIV testing?
The explicit emphasis is on HIV, but the description also notes that transfusion-transmissible infection testing in strong laboratory systems can include other infections depending on national policy (for example, hepatitis B, hepatitis C, and syphilis).
Why does the announcement emphasize lowering HIV prevalence among blood donors?
The emphasis points to prevention-oriented donor selection and repeat donor strategies, since repeat voluntary donors who are regularly screened and educated tend to have lower HIV prevalence than first-time or replacement donors.
What is the role of donor selection and retention in this opportunity?
The award supports donor selection and retention strategies intended to reduce the likelihood of collecting blood from higher-risk populations, including recruiting and retaining low-risk donors over time.
What is the funding activity category?
The funding activity category is health.
What legal authorities support this program?
The legal authority comes from Public Law 108-25 (the United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act of 2003) and Public Law 110-293 (the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008).
How do these laws relate to the grant's objectives?
They provide the basis for PEPFAR programming and support activities that prevent new HIV infections, including preventing HIV transmission through medical procedures such as transfusion.
When was the opportunity posted?
The opportunity was posted on January 15, 2010.
When did the application period close?
The original and current closing date was March 16, 2010.
When was the opportunity archived?
The archive date was April 15, 2010.
What was the eligibility category listed?
Eligibility is described as "Others (see text field entitled Additional Information on Eligibility for clarification)," indicating the eligible applicant pool was defined in the full notice rather than a single standard category.
Does the summary specify exactly which organizations were eligible?
No. The summary indicates that eligibility details were in the full announcement. It notes that, in many CDC international cooperative agreements, the "Others" category can include non-profits, NGOs, academic institutions, and other organizations with demonstrated capacity to implement national-scale public health programs in collaboration with host-country entities, but the specific conditions would be in the full notice.
Who was the award intended to support operationally?
It was aimed at helping Uganda maintain and improve a reliable national blood safety program through support to NBTS, including recruitment of low-risk donors, safe collection, accurate testing, and ensuring only safe blood is released for transfusion.
How would CDC typically engage with the recipient during implementation?
CDC would generally engage through technical guidance, collaborative planning, performance monitoring, and ensuring alignment with PEPFAR strategies and reporting requirements.
Who could be contacted for help accessing the full announcement or for questions?
CDC provided a point of contact through PGO TIMS grants at 770-488-2700 and a general email address (as listed in the opportunity).
What is the overall takeaway of this opportunity?
It is a PEPFAR-funded, CDC-supported cooperative agreement designed to reinforce Uganda's national blood safety system so that transfusions do not contribute to HIV transmission and so donor recruitment and screening approaches progressively reduce HIV prevalence within the donor pool.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: RECOVERY Pacific Crest Trail Maintenance Team
Previous opportunity: PHS 2010 02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR R41/R42)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS10 1026
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS10 1026) also looked into and applied for these:
| Funding Opportunity |
|---|
| Supporting the Ghana Heath Service (GHS) in the Strengthening of National Health Management Systems in the Areas of Strategic Information Systems, Blood Safety, and Laboratory Capacity Building under the President s Emergency Plan for AIDS Relief (PE Apply for CDC RFA PS10 1044 Funding Number: CDC RFA PS10 1044 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening the Capacity of the National AIDS Control Committee to Ensure Prevention of HIV Infection in Health care Settings at National, Regional and District Levels in the Republic of Cameroon under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA PS10 1042 Funding Number: CDC RFA PS10 1042 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Improving the Capacity of the Southern Province Medical Office in the Management of HIV/AIDS/STI/TB Services in the Southern Province of the Republic of Zambia under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10107 Funding Number: CDC RFA PS10 10107 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Substance Abuse and HIV Prevention Ready To Respond Initiative in Communities Highly Impacted by Substance Use and HIV Infection Apply for SP 10 003 Funding Number: SP 10 003 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $300,000 |
| Drug Free Communities Support Program Apply for SP 10 005 Funding Number: SP 10 005 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $125,000 |
| Assuring a Safe and Adequate Blood Supply through Strengthening Government Capacity in the Democratic Republic of Congo under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1097 Funding Number: CDC RFA PS10 1097 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $750,000 |
| Improving Patient Care Through the Strengthening of TB/HIV Collaborative Activities in the United Republic of Tanzania Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1059 Funding Number: CDC RFA PS10 1059 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Scaling up Comprehensive Positive Prevention under the Presidents Emergency Plan for AIDS Relief, in the Republic of MozambiqueUnder the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1078 Funding Number: CDC RFA PS10 1078 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,200,000 |
| Expanded Support for Healthcare Systems Strengthening Activities within the Ministry of Health and Social Services in the Republic of Namibia under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1095 Funding Number: CDC RFA PS10 1095 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Strategic Information and Laboratory Quality Assurance Services to Improve the Monitoring and Delivery of HIV/AIDS Services in the Democratic Republic of Congo under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1098 Funding Number: CDC RFA PS10 1098 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Inform Decision Makers to Act (IDEA) APS Apply for MOAAGHPOP 19 0110 Funding Number: MOAAGHPOP 19 0110 Agency: Agency for International Development Category: Health Funding Amount: $15,000,000 |
| Faculty Development Integrated Technology into Nursing Education and Practice Initiative Apply for HRSA 10 061 Funding Number: HRSA 10 061 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Small Health Care Provider Quality Improvement Apply for HRSA 10 045 Funding Number: HRSA 10 045 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Prevention and Management of Healthcare Associated Infections (R18) Apply for PA 10 089 Funding Number: PA 10 089 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| ARRA OS Recovery Act 2009 Limited Competition Scalable Distributed Research Networks for Comparative Effectiveness Research (R01) Apply for RFA HS 10 015 Funding Number: RFA HS 10 015 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $2,770,000 |
| Improving Patient Safety through Simulation Research (R18) Apply for RFA HS 10 018 Funding Number: RFA HS 10 018 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $350,000 |
| NINDS Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows in MD PhD programs (F31) Apply for PAR 10 091 Funding Number: PAR 10 091 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| SSA Work Incentives Planning and Assistance Projects Apply for SSA OAG 10 1 Funding Number: SSA OAG 10 1 Agency: ODISP OESP Category: Health Funding Amount: $300,000 |
| Medicare Rural Hospital Flexibility Apply for HRSA 10 049 Funding Number: HRSA 10 049 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Part C CAPACITY DEVELOPMENT Apply for HRSA 10 018 Funding Number: HRSA 10 018 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS10 1026", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.